Bcl-2 expression and triple negative profile in breast carcinoma
✍ Scribed by Imen Kallel-Bayoudh; Hanen Ben Hassen; Abdelmajid Khabir; Noureddine Boujelbene; Jamel Daoud; Mounir Frikha; Tahia Sallemi-Boudawara; Sami Aifa; Ahmed Rebaï
- Book ID
- 107577308
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 396 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The bcl-2 gene encodes for a protein that is involved in cell death regulation. it frequently is expressed in breast tumors, in which it is associated with favorable prognostic factors. it has been suggested that bcl-2 also may act as a modulator of response to chemotherapy and/or en
## Background: The bcl-2 gene encodes a protein that blocks apoptosis and might help to promote tumor development. it is expressed in a high percentage of breast tumors and is associated with good prognostic features. however, the mechanisms that regulate bcl-2 expression in breast carcinoma are un
favorable prognostic factors, including a lower number of positive lymph nodes, Texas. absence of p53 protein accumulation, estrogen receptor (ER) and progesterone 3 University of Texas M. D. Anderson Cancer receptor (PR) positivity, diploidy, and a lower proliferative rate. However, although Cente